Valeo Pharma (TSE:VPH) has released an update.
Valeo Pharma Inc. is streamlining its commercial field operations to improve profit margins and reduce operating costs, with the objective of becoming profitable more quickly. The restructuring, which includes downsizing its workforce by approximately 20%, is expected to save over $7 million annually when combined with prior cost-saving measures. The company remains dedicated to its specialty units despite the changes, and extends gratitude to the affected employees for their service.
For further insights into TSE:VPH stock, check out TipRanks’ Stock Analysis page.
